new version V2017

Dovitinib multi target TKI
Description Results

CHIR-258 - CHIR258 - CHIR 258 - dovitinib - TKI-258 - TKI258 - TKI 258      

  • Group by...

pdf
TrialStudied treatmentControl treatmentpatientsROBResultNCT

renal-cell carcinoma (advanced)

GOLDdovitinibsorafenibNegativeNCT01223027



- About - Browse pathology | treatment - Site map - Credits Made with in Lyon - Contact us - Privacy policy - Licence Creative Commons